Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to demonstrate that the fixed dose combination of
telmisartan 40mg + amlodipine 10mg (T40/A10) or the fixed dose combination of telmisartan
80mg + amlodipine 10mg (T80/A10) is superior in reducing blood pressure at eight weeks
compared with amlodipine 10mg monotherapy (A10) in patients who fail to respond to six weeks
treatment with A10.